Analysis of Cutaneous and Hematologic Disorders by High-Throughput Nucleic Acid Sequencing



Status:Recruiting
Conditions:Skin and Soft Tissue Infections, Infectious Disease, Lymphoma, Hematology
Therapuetic Areas:Dermatology / Plastic Surgery, Hematology, Immunology / Infectious Diseases, Oncology
Healthy:No
Age Range:18 - Any
Updated:6/16/2016
Start Date:June 2011
End Date:April 2017
Contact:Alexander Ungewickell
Email:ungewica@stanford.edu
Phone:650-723-6661

Use our guide to learn which trials are right for you!

The goal of this study is to identify genetic changes associated with the initiation,
progression, and treatment response of response of cutaneous and hematologic disorders using
recently developed high-throughput sequencing technologies. The improved understanding of
the genetic changes associated with cutaneous and hematologic disorders may lead to improved
diagnostic, prognostic and therapeutic options for these disorders.


Inclusion Criteria:

- 18 years of age or older

- Patient meets the clinical and/or pathologic criteria for the cutaneous or
hematologic disorder being examined.

- Patient is willing to provide skin biopsies and five 10 mL tubes of peripheral blood.

Exclusion Criteria:

- Less than 18 years of age
We found this trial at
1
site
291 Campus Dr
Stanford, California 94305
(650) 725-3900
Stanford University School of Medicine Vast in both its physical scale and its impact on...
?
mi
from
Stanford, CA
Click here to add this to my saved trials